Try our beta test site
3 studies found for:    12086760 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial
Condition: Metabolic Syndrome
Interventions: Drug: acarbose;   Drug: placebo
2 Recruiting Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes
Conditions: Prediabetic State;   Insulin Resistance
Interventions: Drug: Linagliptin + metformin;   Other: Metformin
3 Terminated Prevention of Diabetes and Hypertension
Conditions: Diabetes Mellitus;   Hypertension
Interventions: Behavioral: Diet;   Behavioral: Moderate exercise;   Drug: enalapril tablets;   Drug: placebo tablets;   Drug: Losartan Tablets

Study has passed its completion date and status has not been verified in more than two years.